Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.8.0.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2017
Dec. 31, 2016
Current assets:    
Cash $ 90,173 $ 55,533
Prepaid expenses and other current assets 21,000 247,321
Total current assets 111,173 302,854
Property Plant and Equipment, net 1,064 15,825
Patents, net 4,500,000
Total assets 4,612,237 318,679
Current Liabilities    
Accounts payable and accrued expenses 2,714,041 4,727,247
Short term advances 20,323 5,823
Notes payable, net of discounts of $2,624,984 as of December 31, 2017 and $1,145,849 as of December 31, 2016 4,461,160 1,878,107
Notes payable - related parties 270,000 170,000
Derivative liability 5,939,600 1,927,752
Current portion of long term loan 4,221 12,395
Total current liabilities 13,409,345 8,721,324
Series C preferred stock liability, net of discounts of $101,808 at December 31, 2017 and $0 as of December 31, 2016 598,192
Long term loan 4,221
Acquisition payable 155,000 155,000
Total liabilities 14,162,537 8,880,545
COMMITMENTS AND CONTINGENCIES
Shareholders' deficit    
Super AA super voting preferred stock, $0.001 par value; 1,000,000 authorized and 5,000 and 1,000 issued and outstanding at December 31, 2017 and December 31, 2016 5
Series B convertible preferred stock, $0.0001 par value; 50,000 shares authorized, 0 shares issued and outstanding at December 31, 2017 and December 31, 2016
Common stock, $.0001 par value; 500,000,000 shares authorized; 316,951,712 and 134,336,637 shares issued and outstanding as of December 31, 2017 and December 31, 2016 31,692 13,434
Additional paid-in capital 19,604,016 9,800,553
Stock subscriptions (1,570) (1,570)
Accumulated deficit (29,184,443) (18,374,283)
Total shareholders' deficit (9,550,300) (8,561,866)
Total liabilities and shareholders' deficit $ 4,612,237 $ 318,679